Press "Enter" to skip to content
FDA Headquarters

Breaking News: FDA approves Pfizer-BioNTech coronavirus vaccine booster for older Americans and those at high risk of illness

Article Read In
FDA Headquarters with FDA Logo

Breaking News: a couple moments ago the FDA, the Food and Drug Administration approved for the us of Pfizer-BioNTech booster shot for those at risk, who are elderly 65 or older, or physically weaker than the rest of the U.S population which can cause them severe illnesses. The FDA authorized an emergency use for the booster shot. But the FDA doesn’t have the final say on this The Centers for Disease Control and Prevention and its advisers board members must allow its use by a recommended detailed decree of who is able to take the booster shot. Over 54 million Americans are elderly over or are the age of 65. Over 54 million people are able to take the shot if the CDC recommends its use as the FDA emergency use.

2 Comments

Comments are closed, but trackbacks and pingbacks are open.

%d bloggers like this: